BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29403557)

  • 1. High secreted protein acidic and rich in cysteine expression in peritumoral fibroblasts predicts better prognosis in patients with resectable gastric cancer.
    Nakajima M; Yoshino S; Kanekiyo S; Maeda N; Sakamoto K; Tsunedomi R; Suzuki N; Takeda S; Yamamoto S; Hazama S; Hoshii Y; Oga A; Itoh H; Ueno T; Nagano H
    Oncol Lett; 2018 Jan; 15(1):803-812. PubMed ID: 29403557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma.
    Infante JR; Matsubayashi H; Sato N; Tonascia J; Klein AP; Riall TA; Yeo C; Iacobuzio-Donahue C; Goggins M
    J Clin Oncol; 2007 Jan; 25(3):319-25. PubMed ID: 17235047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Secreted Protein Acidic and Rich in Cysteine (SPARC) Expression on Prognosis After Surgical Resection for Biliary Carcinoma.
    Toyota K; Murakami Y; Kondo N; Uemura K; Nakagawa N; Takahashi S; Sueda T
    J Gastrointest Surg; 2017 Jun; 21(6):990-999. PubMed ID: 28342122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change of SPARC expression after chemotherapy in gastric cancer.
    Gao YY; Han RB; Wang X; Ge SH; Li HL; Deng T; Liu R; Bai M; Zhou LK; Zhang XY; Ba Y; Huang DZ
    Cancer Biol Med; 2015 Mar; 12(1):33-40. PubMed ID: 25859409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma.
    Cheng CT; Chu YY; Yeh CN; Huang SC; Chen MH; Wang SY; Tsai CY; Chiang KC; Chen YY; Ma MC; Liu CT; Chen TW; Yeh TS
    Onco Targets Ther; 2015; 8():1899-907. PubMed ID: 26251613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of secreted protein, acidic and cysteine-rich gene expression in patients with stage II/III gastric cancer following curative resection and adjuvant chemotherapy with S-1.
    Suzuki Y; Oshima T; Yoshihara K; Sakamaki K; Aoyama T; Cho H; Shiozawa M; Yoshikawa T; Rino Y; Imada T; Masuda M
    Oncol Lett; 2018 May; 15(5):7335-7343. PubMed ID: 29725448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secreted protein acidic and rich in cysteine expression in human colorectal cancer predicts postoperative prognosis.
    Liu QZ; Gao XH; Chang WJ; Wang HT; Wang H; Cao GW; Fu CG
    Eur Rev Med Pharmacol Sci; 2015 May; 19(10):1803-11. PubMed ID: 26044224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of secreted protein acidic and rich in cysteine is an independent prognostic indicator of a poor clinical outcome in oropharyngeal carcinoma patients.
    Yoshida S; Wakisaka N; Kondo S; Moriyama-Kita M; Hirai N; Endo K; Tsuji A; Nakanishi Y; Murono S; Yoshizaki T
    Acta Otolaryngol; 2016; 136(2):189-94. PubMed ID: 26523779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of secreted protein acidic and rich in cysteine in patients with solid tumors.
    Ma Y; Chen H; Ma H; Yao Z; Hu J; Ma J; Zhang X; Chen G; Liu Y
    Saudi Med J; 2019 Aug; 40(8):755-765. PubMed ID: 31423511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPARC expression in gastric cancer predicts poor prognosis: Results from a clinical cohort, pooled analysis and GSEA assay.
    Li Z; Li AD; Xu L; Bai DW; Hou KZ; Zheng HC; Qu XJ; Liu YP
    Oncotarget; 2016 Oct; 7(43):70211-70222. PubMed ID: 28053291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of SPARC expression on the survival of pancreatic ductal adenocarcinoma patients after curative resection.
    Murakawa M; Aoyama T; Miyagi Y; Kobayashi S; Ueno M; Morimoto M; Numata M; Yamamoto N; Tamagawa H; Yukawa N; Rino Y; Masuda M; Morinaga S
    J Cancer; 2019; 10(3):627-633. PubMed ID: 30719160
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic impact of tumoral and/or peri-tumoral stromal SPARC expressions after surgery in patients with biliary tract cancer.
    Nakashima S; Kobayashi S; Sakai D; Tomokuni A; Tomimaru Y; Hama N; Wada H; Kawamoto K; Marubashi S; Eguchi H; Matsuura N; Doki Y; Mori M; Nagano H
    J Surg Oncol; 2014 Dec; 110(8):1016-22. PubMed ID: 25155283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic value of secreted protein acidic and rich in cysteine in the diffuse large B-cell lymphoma.
    Pan PJ; Liu JX
    World J Clin Cases; 2021 Aug; 9(22):6287-6299. PubMed ID: 34434995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical significance of secreted protein acidic and rich in cysteine expression in breast cancer tissue and its association with prognosis.
    Guo W; Zhang M; Chen Y; Guo S
    J Cancer Res Ther; 2017; 13(5):833-836. PubMed ID: 29237913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and prognostic significance of SPARC expression in gastric cancer: A meta‑analysis and bioinformatics analysis.
    Sun J; Bai YK; Fan ZG
    Oncol Lett; 2023 Jun; 25(6):240. PubMed ID: 37181948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of SPARC expression in pancreatic cancer progression and patient survival.
    Gundewar C; Sasor A; Hilmersson KS; Andersson R; Ansari D
    Scand J Gastroenterol; 2015; 50(9):1170-4. PubMed ID: 25765175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased SPARC expression is associated with neoadjuvant therapy in resectable pancreatic ductal adenocarcinoma.
    Hartley C; Rowan D; Chen X; Gomez-Arellano L; West AM; Oshima K; Mackinnon AC
    Pract Lab Med; 2020 Aug; 21():e00171. PubMed ID: 32548230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Secreted Protein Acidic and Rich in Cysteine in the Stroma of a Colorectal Carcinoma is Associated With Patient Prognosis.
    Kim JY; Jeong D; Ahn TS; Kim HJ; Park DS; Park SY; Bae SB; Lee S; Lee SS; Lee MS; Cho HD; Baek MJ
    Ann Coloproctol; 2013 Jun; 29(3):93-9. PubMed ID: 23862126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPARC mRNA expression as a prognostic marker for pancreatic adenocarcinoma patients.
    Miyoshi K; Sato N; Ohuchida K; Mizumoto K; Tanaka M
    Anticancer Res; 2010 Mar; 30(3):867-71. PubMed ID: 20393008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients.
    Nagai MA; Gerhard R; Fregnani JH; Nonogaki S; Rierger RB; Netto MM; Soares FA
    Breast Cancer Res Treat; 2011 Feb; 126(1):1-14. PubMed ID: 20369286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.